Neumora Therapeutics Stock Quote NMRA - Stock Price, News, Charts, Message Board, Trades

Unlock more advanced trading tools

Join ADVFN today

Current Price

9.15

Bid

7.25

Ask

9.52

Volume

677,291

8.82 Day's Range 9.31

8.82 52 Week Range 21.00

Market Cap

1.454B

Previous Close

9.06

Open

8.94

Last Trade

9.33

Last Trade Time

Financial Volume

$ 6,167,518

VWAP

9.1062

Average Volume (3m)

588,480

Shares Outstanding

158,886,101

Dividend Yield

PE Ratio

-6.16

Earnings Per Share (EPS)

-1.48

Revenue

Net Profit

-235.93M

Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases. The company develops navacaprant (NMRA-140), a novel once-daily oral kappa opioid receptor antagonist, ... Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases. The company develops navacaprant (NMRA-140), a novel once-daily oral kappa opioid receptor antagonist, which is in phase 3 clinical trials for the treatment of major depressive disorder. It also develops NMRA-511 that is in phase 1 clinical trials in patients with agitation associated with dementia due to Alzheimer's disease; NMRA-266 for the treatment of schizophrenia and other neuropsychiatric disorders; NMRA-NMDA for the treatment of schizophrenia; NMRA-CK1d, a CK1d inhibitor program for the treatment of amyotrophic lateral sclerosis; NMRA-NLRP3 for the treatment of certain neurodegenerative conditions; and NMRA-GCase for the treatment of Parkinson's disease. The company was formerly known as RBNC Therapeutics, Inc. and changed its name to Neumora Therapeutics, Inc. in October 2021. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.neumoratx.com.

Headquarters

New Castle, Delaware, USA

Founded

1970

Neumora Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker NMRA. The last closing price for Neumora Therapeutics was $9.06. Over the last year, Neumora Therapeutics shares have traded in a share price range of $ 8.82 to $ 21.00.

Neumora Therapeutics currently has 158,886,101 shares outstanding. The market capitalization of Neumora Therapeutics is $1.45 billion. Neumora Therapeutics has a price to earnings ratio (PE ratio) of -6.16.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-1.41	-13.3522727273	10.56	10.74	8.82	598722	9.81526009	CS
4	-4.76	-34.2199856219	13.91	14.95	8.82	640945	12.07141047	CS
12	-6.13	-40.1178010471	15.28	21	8.82	588480	14.15916397	CS
26	-2.44	-21.0526315789	11.59	21	8.82	417809	14.0592033	CS
52	-7.35	-44.5454545455	16.5	21	8.82	425434	13.65179118	CS
156	-7.35	-44.5454545455	16.5	21	8.82	425434	13.65179118	CS
260	-7.35	-44.5454545455	16.5	21	8.82	425434	13.65179118	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
BDRXBiodexa Pharmaceuticals PLC	$ 1.3254 (82.86%)	70.82M
IBRXImmunityBio Inc	$ 7.35 (43.84%)	40.28M
AGENAgenus Inc	$ 11.685 (40.78%)	3.37M
ULHUniversal Logistics Holdings Inc	$ 45.63 (38.74%)	484.22k
NIVFNewGenIvf Group Ltd	$ 1.77 (36.15%)	57.78M
MFImF International Ltd	$ 2.3153 (-77.82%)	21.23M
NWGLNature Wood Group Ltd	$ 5.05 (-70.03%)	2.48M
ICLKiClick Interactive Asia Group Ltd	$ 1.21 (-52.17%)	719.95k
NUWENewellis Inc	$ 0.1695 (-41.35%)	18.46M
SGBXSafe and Green Holdings Corporation	$ 0.1469 (-32.92%)	8.39M
PEGYPineapple Energy Inc	$ 0.065499 (26.20%)	325.57M
SQQQProShares UltraPro Short QQQ	$ 11.43 (-4.75%)	137.28M
INTCIntel Corporation	$ 31.88 (-9.20%)	119.84M
TSLATesla Inc	$ 168.29 (-1.11%)	109.84M
SOFISoFi Technologies Inc	$ 7.87 (3.69%)	88.63M